Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial. Swiss Med Wkly [Internet]. 2024 Apr. 15 [cited 2025 Oct. 14];154(4):3762. Available from: https://smw.ch/index.php/smw/article/view/3762